![](https://investorshub.advfn.com/uicon/9451.png?cb=1515574580)
Sunday, March 02, 2014 10:53:16 PM
I'm on the other hand, don't think ATRS will make generic Copaxone, unless TEVA is the manufacturer.
The reason: ATRS is buying the drug from someone else and packaging it with the injector, if they buy and sell someone else drug, this might hurt the TEVA relationship and I don't think ATRS will go this route, unless there is a major change in Teva business ( buyout) that will have major impact on the mutual projects.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM